The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
David Wise
Stock and Other Ownership Interests - Doximity
Honoraria - OncLive; ScientiaCME
Consulting or Advisory Role - Bayer; Janssen; K36; OncoC4; Pfizer
Travel, Accommodations, Expenses - Bayer; Bayer; Pfizer
 
Tian Zhang
Leadership - Archimmune Therapeutics (I); Capio BioSciences (I)
Stock and Other Ownership Interests - Archimmune Therapeutics (I); Capio Biosciences (I); Nanorobotics (I)
Honoraria - Aptitude Health; Clinical Care Options; Curio Science; Dava Oncology; Mashup Media; MJH Life Sciences; Peerview
Consulting or Advisory Role - AstraZeneca; AVEO; Bayer; Bristol-Myers Squibb; Dendreon; Eisai; EMD Serono; Exelixis; Gilead Sciences; Johnson & Johnson/Janssen; Lilly; Loxo/Lilly; Merck; Novartis; Pfizer; Xencor
Research Funding - ALX Oncology (Inst); Astellas Pharma (Inst); Bayer (Inst); Exelixis (Inst); Janssen (Inst); Janux Therapeutics (Inst); Kura Oncology (Inst); Loxo/Lilly (Inst); Merck (Inst); OncoC4; Pfizer (Inst); Tempus (Inst)
Patents, Royalties, Other Intellectual Property - Circulating tumor cell novel capture by c-MET technology (Inst); Prochelators as Targeted Prodrugs for Prostate Cancer (Inst)
Travel, Accommodations, Expenses - Bayer; Janux Therapeutics; Johnson & Johnson/Janssen
Other Relationship - ASCO; Kidney Cancer Association; KidneyCan; Myrovlytis Trust; Winn Foundation
 
Biren Saraiya
Stock and Other Ownership Interests - Meaningful Conversations and Leadership LLC
Consulting or Advisory Role - Johnson & Johnson/Janssen
Research Funding - Hookipa Pharma (Inst); Merck (Inst); OncoC4 (Inst); Regeneron (Inst)
 
Jose Avitia
No Relationships to Disclose
 
Andrew Armstrong
Consulting or Advisory Role - Astellas Scientific and Medical Affairs Inc; AstraZeneca; Bayer; Boundless Bio; Bristol-Myers Squibb; Cytogen; Exelixis; GoodRx; Janssen; Merck; Myovant Sciences; Novartis; Pfizer; Precede Bio; Sumitomo Pharma Oncology
Research Funding - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Merck (Inst); Novartis (Inst); pathos (Inst); Pfizer (Inst); Syntrix Biosystems (Inst)
Patents, Royalties, Other Intellectual Property - Circulating tumor cell novel capture technology (Inst)
Travel, Accommodations, Expenses - Astellas Scientific and Medical Affairs Inc
 
Shuchi Gulati
Honoraria - ASCO; Horizon CME; MashupMedia
Consulting or Advisory Role - AVEO; Eisai; EMD Serono; Puma Biotechnology
Research Funding - AstraZeneca
Patents, Royalties, Other Intellectual Property - Patent pending for: "Diagnostic tools for prediction of survival and responsiveness to treatments.” US17327100.
Travel, Accommodations, Expenses - ASCO; Conquer Cancer Foundation; Horizon CME; Meetings, Events and Conference Coordinators Inc.
 
Manojkumar Bupathi
Honoraria - Agendia; AIQ Solutions; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; EMD Serono; Exelixis; Exelixis; Exelixis; Exelixis; Janssen; Myovant Sciences; Pfizer
Consulting or Advisory Role - AstraZeneca; AstraZeneca; Bristol-Myers Squibb; Exelixis
Speakers' Bureau - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Exelixis; Janssen Oncology; Pfizer
 
Alexandra Sokolova
Honoraria - Astellas Pharma; AstraZeneca; Bayer; CELC-G; Dava Oncology
Research Funding - AstraZeneca (Inst); Janssen Oncology (Inst); Novartis (Inst); Regeneron (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Lantheus Medical Imaging
 
Ronald Tutrone
Employment - Chesapeake Urology
Stock and Other Ownership Interests - Compass Therapeutics; GlaxoSmithKline; ImmnityBio; Novartis; Urogen pharma; Veru
Consulting or Advisory Role - Exosome Diagnostics; Myovant Sciences; Novartis; Nymox
Speakers' Bureau - Medivation/Astellas; Pfizer
Research Funding - Advantagene (Inst); Arvinas (Inst); AstraZeneca (Inst); Bayer (Inst); Blue Earth Diagnostics (Inst); Dendreon (Inst); ESSA (Inst); Exosome Diagnostics (Inst); Francis Medical (Inst); Genomic Health (Inst); Janssen Oncology (Inst); Lantheus Medical Imaging (Inst); Lilly (Inst); MDxHealth (Inst); Medivation/Astellas (Inst); Merck (Inst); POINT Biopharma (Inst); Propella Therapeutics (Inst)
 
Svetlana Shpyro
Employment - BioNTech
Stock and Other Ownership Interests - BioNTech
Patents, Royalties, Other Intellectual Property - BioNTech
 
Olga Blokhina
Employment - BioNTech; Johnson & Johnson (I)
Stock and Other Ownership Interests - BioNTech; Johnson & Johnson (I)
 
Qiong Wang
Employment - BioNTech SE
Stock and Other Ownership Interests - BioNTech SE
Travel, Accommodations, Expenses - BioNTech SE
 
Yang Liu
No Relationships to Disclose
 
Joan Durbin
Employment - OncoC4
Patents, Royalties, Other Intellectual Property - Royalties from patent
 
Pan Zheng
Employment - OncoC4
Leadership - OncoC4
Stock and Other Ownership Interests - OncoC4
Patents, Royalties, Other Intellectual Property - Patent on ONC-392, a new next generation anti-CTLA-4 antibody.
 
Mark Stein
Stock and Other Ownership Interests - Rafael Holdings
Consulting or Advisory Role - Exelixis; GI Innovation; Johnson & Johnson/Janssen
Research Funding - ARTBIO (Inst); AstraZeneca (Inst); Bicycle Therapeutics (Inst); Bristol-Myers Squibb (Inst); DualityBio (Inst); Exelixis (Inst); Johnson & Johnson/Janssen (Inst); Lilly (Inst); Regeneron (Inst); Telix Pharmaceuticals (Inst); Xencor (Inst)